NCT02822898

Brief Summary

The prescription of intravenous maintenance solutions - although widespread - lacks important data on the optimal sodium and potassium content, which has given rise to an important debate in the scientific literature. Our study compares two different infusion fluids in 12 healthy adult volunteers without renal failure in a single-blind randomized crossover design over two 48 hour periods during which subjects are not allowed to eat or drink. Fluid 1 is a premixed solution containing 54 mmol/L of sodium and 26 mmol/L of potassium; fluid 2 is sodium chloride 0.9% in glucose 5% with 40 mmol/L of potassium. Both solutions are administered at 25 mL/kg of ideal body weight, as recommended by current guidelines (NICE 174) and both solutions are widely used in daily clinical practice. The primary hypothesis is that isotonic maintenance solutions lead to more fluid retention than hypotonic fluids. Metabolism of both solutions is assessed by sequential analysis of urine and serum, clinical parameters and bioelectrical impedance analysis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Jun 2016

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2016

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

June 27, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 6, 2016

Completed
26 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
Last Updated

August 9, 2016

Status Verified

August 1, 2016

Enrollment Period

2 months

First QC Date

June 27, 2016

Last Update Submit

August 7, 2016

Conditions

Keywords

MaintenanceIntravenous solutionsIntravenous fluidsTonicityPotassiumSodiumFluid retention

Outcome Measures

Primary Outcomes (2)

  • Urine Output

    Urinary output over study period (as AUC).

    48h

  • Body weight

    Body weight over study period (as AUC), used as a back up parameter for urinary output.

    48h

Secondary Outcomes (4)

  • Amount of sodium retention / excretion (excreted sodium / administered sodium)

    48h

  • Number of episodes of hypokalemia (<3.5 mmol/L), hyponatremia (<135 mmol/L), hypernatremia (>145 mmol/L)

    48h

  • Change of sodium level from its baseline value.

    48h

  • Change of sodium and potassium level from its baseline value.

    48h

Other Outcomes (15)

  • Osmoregulatory Profile 1: urinary volume (mL)

    48h

  • Osmoregulatory Profile 2: urinary osmolality (mOsm/kg)

    48h

  • Osmoregulatory Profile 3: serum antidiuretic hormone (ADH) (pg/mL)

    48h

  • +12 more other outcomes

Study Arms (2)

Isotonic Maintenance Fluid

ACTIVE COMPARATOR

Isotonic Maintenance Fluid

Drug: NaCl 0.9% in Glucose 5% with 40mEq Potassium

Hypotonic Maintenance Fluid

ACTIVE COMPARATOR

Hypotonic Maintenance Fluid

Drug: Glucion 5%

Interventions

NaCl 0.9% in Glucose 5% with 40mEq Potassium, administered at 25 mL/kg IBW/h for 48h

Isotonic Maintenance Fluid

Glucion 5% (premixed solution containing 54 mmol/L sodium and 26 mmol/L potassium amongst others), administered at 25 mL/kg IBW/h for 48h

Hypotonic Maintenance Fluid

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy adults, 18-70 years of age
  • BMI 17-45 kg/m².
  • Creatinine clearance \>60 ml/min (according to eGFR CKD-EPI formula).

You may not qualify if:

  • Acute medical illness within 3 weeks of first study period
  • Chronic medication: under diuretic therapy or other chronic medication that interfere with urine output or induce urine retention. All chronic medication should be declared before being enrolled in the study.
  • Medical history:
  • cardiac failure,
  • malnourishment,
  • diabetes mellitus,
  • urological disease preventing spontaneous or complete emptying of the bladder,
  • any medical or non-medical issue preventing complaint-free fasting for 48 hours (e.g. active peptic ulcer, psychosis, substance abuse…)
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital, Antwerp

Edegem, 2650, Belgium

Location

Related Publications (3)

  • Lobo DN, Bostock KA, Neal KR, Perkins AC, Rowlands BJ, Allison SP. Effect of salt and water balance on recovery of gastrointestinal function after elective colonic resection: a randomised controlled trial. Lancet. 2002 May 25;359(9320):1812-8. doi: 10.1016/S0140-6736(02)08711-1.

    PMID: 12044376BACKGROUND
  • Moritz ML, Ayus JC. Maintenance Intravenous Fluids in Acutely Ill Patients. N Engl J Med. 2015 Oct;373(14):1350-60. doi: 10.1056/NEJMra1412877. No abstract available.

    PMID: 26422725BACKGROUND
  • Van Regenmortel N, De Weerdt T, Van Craenenbroeck AH, Roelant E, Verbrugghe W, Dams K, Malbrain MLNG, Van den Wyngaert T, Jorens PG. Effect of isotonic versus hypotonic maintenance fluid therapy on urine output, fluid balance, and electrolyte homeostasis: a crossover study in fasting adult volunteers. Br J Anaesth. 2017 Jun 1;118(6):892-900. doi: 10.1093/bja/aex118.

Related Links

MeSH Terms

Interventions

Glucose

Intervention Hierarchy (Ancestors)

HexosesMonosaccharidesSugarsCarbohydrates

Study Officials

  • Niels Van Regenmortel, M.D.

    University Hospital, Antwerp

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Consultant

Study Record Dates

First Submitted

June 27, 2016

First Posted

July 6, 2016

Study Start

June 1, 2016

Primary Completion

August 1, 2016

Study Completion

August 1, 2016

Last Updated

August 9, 2016

Record last verified: 2016-08

Locations